These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23090226)
21. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255 [TBL] [Abstract][Full Text] [Related]
22. [Low prevalence of hepatitis C virus infection in a prisoner population from Maracaibo, Venezuela]. Monsalve-Castillo F; Chacín-Bonilla L; Atencio RJ; Porto LD; Costa-León LA; Estévez JE; Callejas-Valero DE Biomedica; 2009 Dec; 29(4):647-52. PubMed ID: 20440463 [TBL] [Abstract][Full Text] [Related]
23. Correlates of hepatitis C virus infection among incarcerated Ghanaians: a national multicentre study. Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G J Med Microbiol; 2007 Mar; 56(Pt 3):391-397. PubMed ID: 17314372 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of selected sexually and blood-borne infections in Injecting drug abuser inmates of bandar abbas and roodan correction facilities, Iran, 2002. Davoodian P; Dadvand H; Mahoori K; Amoozandeh A; Salavati A Braz J Infect Dis; 2009 Oct; 13(5):356-8. PubMed ID: 20428635 [TBL] [Abstract][Full Text] [Related]
25. Characteristics associated with anti-HCV serological markers in prisoners in the state of Paraná, Brazil: a case-control study. Silva TMPM; Ferreto LED; Follador FAC; Vieira AP; Yamada RS; Lucio LC; Titon JP; Torres RH; Amaral GCD; Coelho HC Braz J Infect Dis; 2019; 23(3):173-181. PubMed ID: 31228459 [TBL] [Abstract][Full Text] [Related]
26. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723 [TBL] [Abstract][Full Text] [Related]
27. A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users. Kim AY; Nagami EH; Birch CE; Bowen MJ; Lauer GM; McGovern BH Hepatology; 2013 Mar; 57(3):944-52. PubMed ID: 23111904 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis C prevalence among HIV-positive MSM in San Francisco: 2004 and 2008. Raymond HF; Hughes A; O'Keefe K; Stall RD; McFarland W Sex Transm Dis; 2011 Mar; 38(3):219-20. PubMed ID: 20938373 [TBL] [Abstract][Full Text] [Related]
29. Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period. Marco A; Gallego C; Caylà JA PLoS One; 2014; 9(2):e90560. PubMed ID: 24587394 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of the viral hepatitis B and C in female prisoners of Metropolitan Regional Prison Complex in the State of Goiás, Central Brazil. Barros LA; Pessoni GC; Teles SA; Souza SM; Matos MA; Martins RM; Del-Rios NH; Matos MA; Carneiro MA Rev Soc Bras Med Trop; 2013; 46(1):24-9. PubMed ID: 23563821 [TBL] [Abstract][Full Text] [Related]
31. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh. Gorar ZA; Zulfikar I J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648 [TBL] [Abstract][Full Text] [Related]
32. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Burattini M; Massad E; Rozman M; Azevedo R; Carvalho H Rev Saude Publica; 2000 Oct; 34(5):431-6. PubMed ID: 11105105 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of Hepatitis B virus and/or Hepatitis C virus co-infections in prisoners infected with the Human Immunodeficiency Virus. Pontali E; Ferrari F Int J Prison Health; 2008; 4(2):77-82. PubMed ID: 18464061 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis. Alonso M; Gutzman A; Mazin R; Pinzon CE; Reveiz L; Ghidinelli M Int J Public Health; 2015 Nov; 60(7):789-98. PubMed ID: 26298439 [TBL] [Abstract][Full Text] [Related]
35. Seroprevalence study of HCV among hospitalized intravenous drug users in Ahvaz, Iran (2001-2006). Alavi SM; Alavi L J Infect Public Health; 2009; 2(1):47-51. PubMed ID: 20701860 [TBL] [Abstract][Full Text] [Related]
36. Prevalence of HCV infection in a prison population of the greater Florianópolis area. Felisberto M; Saretto AA; Wopereis S; Machado MJ; Spada C Rev Soc Bras Med Trop; 2019 Jul; 52():e20190143. PubMed ID: 31340375 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of HCV infection and associated factors among illicit drug users in Breves, State of Pará, northern Brazil. Pacheco SD; Silva-Oliveira GC; Maradei-Pereira LM; Crescente JÂ; Lemos JA; Oliveira-Filho AB Rev Soc Bras Med Trop; 2014; 47(3):367-70. PubMed ID: 24728470 [TBL] [Abstract][Full Text] [Related]
38. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015. Graham S; Maher L; Wand H; Doyle M; Iversen J Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. Holsen DS; Harthug S; Myrmel H Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850 [TBL] [Abstract][Full Text] [Related]
40. Descriptive epidemiology of hepatitis C virus among male heroin abusers in Taiwan. Liao KF; Peng CY; Lai SW; Chang WL; Hsu NY South Med J; 2006 Apr; 99(4):348-51. PubMed ID: 16634243 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]